Plus Therapeutics (PSTV) Asset Utilization Ratio (2016 - 2025)
Plus Therapeutics (PSTV) has disclosed Asset Utilization Ratio for 15 consecutive years, with 0.36 as the latest value for Q3 2025.
- On a quarterly basis, Asset Utilization Ratio fell 42.87% to 0.36 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.36, a 42.87% decrease, with the full-year FY2024 number at 0.65, up 131.91% from a year prior.
- Asset Utilization Ratio was 0.36 for Q3 2025 at Plus Therapeutics, down from 0.48 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.86 in Q4 2024 to a low of 0.06 in Q1 2021.
- A 5-year average of 0.28 and a median of 0.22 in 2023 define the central range for Asset Utilization Ratio.
- Peak YoY movement for Asset Utilization Ratio: skyrocketed 4847.39% in 2023, then plummeted 42.87% in 2025.
- Plus Therapeutics' Asset Utilization Ratio stood at 0.04 in 2021, then skyrocketed by 123.41% to 0.01 in 2022, then skyrocketed by 4583.58% to 0.4 in 2023, then soared by 116.18% to 0.86 in 2024, then crashed by 57.97% to 0.36 in 2025.
- Per Business Quant, the three most recent readings for PSTV's Asset Utilization Ratio are 0.36 (Q3 2025), 0.48 (Q2 2025), and 0.56 (Q1 2025).